FNFDCM
TMO icon

Folger Nolan Fleming Douglas Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Folger Nolan Fleming Douglas Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$406K Sell
809
-32
-4% -$15.4K 0.03% 136
2026
Q1 		$413K Hold
841
– – 0.04% 135
2025
Q4 		$487K Hold
841
– – 0.05% 112
2025
Q3 		$408K Sell
841
-41
-5% -$19.1K 0.04% 126
2025
Q2 		$358K Sell
882
-31
-3% -$13K 0.04% 127
2025
Q1 		$454K Sell
913
-5
-0.5% -$2.71K 0.05% 119
2024
Q4 		$478K Hold
918
– – 0.05% 117
2024
Q3 		$568K Sell
918
-45
-5% -$26.6K 0.06% 112
2024
Q2 		$533K Sell
963
-20
-2% -$11.5K 0.05% 110
2024
Q1 		$571K Sell
983
-3
-0.3% -$1.68K 0.06% 110
2023
Q4 		$523K Sell
986
-25
-2% -$12.1K 0.06% 114
2023
Q3 		$512K Sell
1,011
-20
-2% -$10.7K 0.06% 110
2023
Q2 		$538K Sell
1,031
-30
-3% -$16.2K 0.06% 116
2023
Q1 		$612K Sell
1,061
-30
-3% -$16.9K 0.07% 106
2022
Q4 		$601K Sell
1,091
-35
-3% -$18.5K 0.07% 109
2022
Q3 		$571K Sell
1,126
-33
-3% -$18.5K 0.08% 103
2022
Q2 		$630K Sell
1,159
-5
-0.4% -$2.75K 0.08% 105
2022
Q1 		$688K Sell
1,164
-75
-6% -$43.1K 0.08% 107
2021
Q4 		$827K Sell
1,239
-84
-6% -$52.4K 0.09% 103
2021
Q3 		$756K Sell
1,323
-68
-5% -$37.3K 0.09% 100
2021
Q2 		$702K Sell
1,391
-54
-4% -$25.5K 0.08% 105
2021
Q1 		$659K Sell
1,445
-75
-5% -$35.8K 0.08% 103
2020
Q4 		$708K Buy
1,520
+50
+3% +$23.4K 0.09% 101
2020
Q3 		$649K Hold
1,470
– – 0.1% 98
2020
Q2 		$533K Sell
1,470
-20
-1% -$6.7K 0.09% 102
2020
Q1 		$423K Sell
1,490
-20
-1% -$6.31K 0.08% 102
2019
Q4 		$491K Sell
1,510
-85
-5% -$25.8K 0.07% 111
2019
Q3 		$465K Hold
1,595
– – 0.07% 109
2019
Q2 		$468K Sell
1,595
-50
-3% -$13.8K 0.07% 112
2019
Q1 		$450K Hold
1,645
– – 0.07% 109
2018
Q4 		$368K Sell
1,645
-50
-3% -$11.7K 0.06% 115
2018
Q3 		$414K Hold
1,695
– – 0.06% 119
2018
Q2 		$351K Hold
1,695
– – 0.05% 126
2018
Q1 		$350K Hold
1,695
– – 0.05% 126
2017
Q4 		$322K Sell
1,695
-25
-1% -$4.79K 0.04% 132
2017
Q3 		$325K Hold
1,720
– – 0.05% 128
2017
Q2 		$300K Hold
1,720
– – 0.05% 134
2017
Q1 		$264K Sell
1,720
-50
-3% -$7.64K 0.04% 147
2016
Q4 		$281K Hold
1,770
– – 0.05% 139
2016
Q3 		$281K Hold
1,770
– – 0.05% 139
2016
Q2 		$262K Hold
1,770
– – 0.05% 140
2016
Q1 		$251K Sell
1,770
-50
-3% -$6.7K 0.04% 139
2015
Q4 		$258K Hold
1,820
– – 0.05% 139
2015
Q3 		$223K Hold
1,820
– – 0.05% 146
2015
Q2 		$236K Hold
1,820
– – 0.04% 146
2015
Q1 		$244K Sell
1,820
-100
-5% -$12.9K 0.04% 145
2014
Q4 		$241K Hold
1,920
– – 0.04% 144
2014
Q3 		$234K Hold
1,920
– – 0.04% 139
2014
Q2 		$227K Hold
1,920
– – 0.04% 142
2014
Q1 		$231K Hold
1,920
– – 0.05% 136
2013
Q4 		$214K Buy
+1,920
New +$191K 0.04% 147

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Folger Nolan Fleming Douglas Capital Management's TMO Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q2 2026, selling an estimated $15.4K and leaving 809 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #136.

Folger Nolan Fleming Douglas Capital Management first reported a position in TMO in Q4 2013 and has held it in 51 quarters since. The position peaked at $827K in Q4 2021. 827 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 809 shares of Thermo Fisher Scientific worth $406K as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 32 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.4K.
  • Thermo Fisher Scientific made up 0.03% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #136 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 51 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's Thermo Fisher Scientific position peaked at $827K in Q4 2021.
  • 827 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.